a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China

Diabetic Retinopathy Clinical Trial

— SMS  

Official title:

a Randomized Controlled Trail to Determine the Impact of a SMS Reminder Among Diabetic Retinopathy Patients in Rural China

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01837121
• Other study ID #: ZOC-WDF-SMS
• Status: Completed
• Phase: N/A
• First received: April 14, 2013
• Last updated: January 7, 2018
• Start date: January 2015
• Est. completion date: June 2017

Study information

• Verified date: January 2018
• Source: Sun Yat-sen University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to use a randomized controlled design to determine the impact of a SMS messaging intervention on the following outcomes among persons diagnosed with diabetic retinopathy in rural China.

Description:

SMS message reminder is a system which can sent re-visit information to remind the patient about the revisit time and address. The investigators can use the SMS system to find out if it is a useful to reduce the not-attended rate of the revisit appointment among the rural diabetic retinopathy patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 237
• Est. completion date: June 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• all the diabetes patients who would like to join our study in 5 CREST cooperated rural hospitals.

Exclusion Criteria:

1. Both the patient and his/her caretakers don't have cellphone,or the one who has cellphone but don't know how to use the SMS function.

2. The first re-visit appointment time is outside our study period.

Related Conditions & MeSH terms

• Compliance
• Diabetic Retinopathy
• Retinal Diseases
• SMS

Intervention

Other:
• the SMS reminder message
the SMS reminder message will sent to the SMS group patients 1 week and 3 day before there appointment,to remind them the exact time and address of the revisit appointment.

Locations

Country	Name	City	State
China	Blindness Preventment and Treatment Department, Zhongshan Ophthalmic Center	Guangzhou	Guangdong

Sponsors (3)

Lead Sponsor	Collaborator
Sun Yat-sen University	Orbis, The World Diabetes Foundation

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Not-attended rate	Compare the SMS patient not-attended rate with the control group to show the impact of SMS reminder on the compliance with scheduled follow-up visit	up to 1.5 years
Secondary	Knowledge about Diabetic retinopathy on a standardized examination	Using a questionnaire about the comprehensive eye exam and Diabetic retinopathy to compare Knowledge about Diabetic retinopathy on a standardized examination between the SMS group and the control group	up to 1.5 years
Secondary	Presenting vision	Presenting vision(Best corrected visual acuity) in the better-seeing and worse-seeing eyes of the two group	up to 1.5 years
Secondary	Loss of presenting vision	Loss of presenting vision(Best corrected visual acuity) in better-seeing eye thought due to Diabetic retinopathy	up to 1.5 years
Secondary	Satisfaction with care	Using a patient satisfaction questionnaire to compare satisfaction with care between the SMS group and the control group	up tp 1.5 years